客观评估视力表现在不同的读取距离后光滑切割镜片式角膜切割 (SILK) 的近视

Rohit Shetty1, Pooja Khamar1, Raghav Narasimhan2

  • 1Department of Cornea and Refractive Surgery, Narayana Nethralaya, 121/C Chord Road, 1st R Block, Rajajinagar, Bangalore, 560010, India.

Scientific reports
|August 9, 2025
PubMed
概括

顺滑切割镜片角膜切割 (SILK) 手术在中间距离提供了良好的视觉敏度,与缩眼相比较. 这种折射性手术显示出较小的高阶异常诱导,使其成为近视纠正的可行选择.

相关概念视频

Focusing of Light in the Eye01:16

Focusing of Light in the Eye

Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
3.2K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
681
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
568